Spire Healthcare Grants New LTIP Awards to Top Executives

An announcement from Spire Healthcare ( (GB:SPI) ) is now available.

Spire Healthcare has granted new long-term incentive plan awards to chief executive Justin Ash and chief financial officer Harbant Samra in the form of nil-cost options over 736,733 and 451,653 ordinary shares respectively, representing 200% of their current base salaries. The awards, which vest after a performance period ending 31 December 2028 and are then subject to a further two-year holding period, will be tied to performance conditions still being finalised by the remuneration committee to align with the company’s value-creation strategy, highlighting a continued focus on linking executive pay to long-term shareholder returns.

The most recent analyst rating on (GB:SPI) stock is a Hold with a £196.00 price target. To see the full list of analyst forecasts on Spire Healthcare stock, see the GB:SPI Stock Forecast page.

Spark’s Take on SPI Stock

According to Spark, TipRanks’ AI Analyst, SPI is a Neutral.

The score is primarily supported by solid revenue recovery and consistently positive cash generation, but is held back by high leverage and weak net income conversion. Technicals are soft with the price below key moving averages, and valuation looks stretched with a high P/E and modest yield.

To see Spark’s full report on SPI stock, click here.

More about Spire Healthcare

Spire Healthcare Group plc is a UK-based private healthcare provider operating a network of hospitals and clinics. The group offers a range of medical services, including surgery, diagnostics and specialist treatments, serving both insured and self-pay patients in the UK healthcare market.

Average Trading Volume: 1,733,083

Technical Sentiment Signal: Sell

Current Market Cap: £743.6M

Learn more about SPI stock on TipRanks’ Stock Analysis page.